FY2025 EPS Estimates for ADMA Biologics Boosted by Analyst
ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) – Investment analysts at Cantor Fitzgerald increased their FY2025 earnings estimates for shares of ADMA Biologics in a note issued to investors on Thursday, March 20th. Cantor Fitzgerald analyst K. Kluska now expects that the biotechnology company will post earnings per share of $0.73 for the year, up […]
